MedTrace Logo

Patient Reported Outcomes With WaveLight Plus LASIK

NCT07084844 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2025-09-15

No results posted yet for this study

Summary

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

WaveLigh Plus LASIK

Wavelight plus LASIK is an advanced laser eye surgery technology designed to enhance visual outcomes through personalized treatment plans. This system integrates comprehensive diagnostics, including biometry, tomography, and wavefront measurements, to create a tailored ablation profile for each patient.

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Mann Eye Institute

    lead OTHER

Principal Investigators

  • Phillip Brunson · Mann Eye Institute

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-05
Primary Completion
2026-09-01
Completion
2026-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07084844 on ClinicalTrials.gov